Nvwm LLC Decreases Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Nvwm LLC trimmed its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 6.8% during the fourth quarter, Holdings Channel reports. The firm owned 11,829 shares of the exchange traded fund’s stock after selling 858 shares during the quarter. Nvwm LLC’s holdings in SPDR S&P Biotech ETF were worth $1,065,000 at the end of the most recent reporting period.

A number of other hedge funds have also made changes to their positions in XBI. FMR LLC lifted its position in shares of SPDR S&P Biotech ETF by 13.6% in the third quarter. FMR LLC now owns 6,940 shares of the exchange traded fund’s stock valued at $686,000 after acquiring an additional 830 shares in the last quarter. Ameritas Advisory Services LLC increased its holdings in shares of SPDR S&P Biotech ETF by 11.9% during the 4th quarter. Ameritas Advisory Services LLC now owns 10,684 shares of the exchange traded fund’s stock worth $962,000 after buying an additional 1,137 shares during the last quarter. Beaton Management Co. Inc. purchased a new stake in SPDR S&P Biotech ETF during the third quarter valued at about $212,000. Robinson Value Management Ltd. increased its stake in SPDR S&P Biotech ETF by 1.2% during the third quarter. Robinson Value Management Ltd. now owns 13,452 shares of the exchange traded fund’s stock worth $1,329,000 after acquiring an additional 155 shares during the last quarter. Finally, Hollow Brook Wealth Management LLC raised its holdings in shares of SPDR S&P Biotech ETF by 4.9% in the 3rd quarter. Hollow Brook Wealth Management LLC now owns 21,669 shares of the exchange traded fund’s stock worth $2,141,000 after purchasing an additional 1,003 shares during the period.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA:XBI opened at $92.57 on Wednesday. The stock has a 50-day simple moving average of $92.99 and a 200-day simple moving average of $96.59. The stock has a market capitalization of $7.06 billion, a P/E ratio of 11.47 and a beta of 1.11. SPDR S&P Biotech ETF has a 1 year low of $81.14 and a 1 year high of $105.47.

About SPDR S&P Biotech ETF

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.